267 related articles for article (PubMed ID: 23026511)
1. 1α,25(OH)2-dihydroxyvitamin D3/VDR protects the skin from UVB-induced tumor formation by interacting with the β-catenin pathway.
Jiang YJ; Teichert AE; Fong F; Oda Y; Bikle DD
J Steroid Biochem Mol Biol; 2013 Jul; 136():229-32. PubMed ID: 23026511
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal role of vitamin D receptor on β-catenin regulated keratinocyte proliferation and differentiation.
Hu L; Bikle DD; Oda Y
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():237-41. PubMed ID: 24239508
[TBL] [Abstract][Full Text] [Related]
3. The vitamin D receptor: a tumor suppressor in skin.
Bikle DD
Discov Med; 2011 Jan; 11(56):7-17. PubMed ID: 21276406
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor-null mice.
Teichert AE; Elalieh H; Elias PM; Welsh J; Bikle DD
J Invest Dermatol; 2011 Nov; 131(11):2289-97. PubMed ID: 21814234
[TBL] [Abstract][Full Text] [Related]
5. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis.
Ellison TI; Smith MK; Gilliam AC; MacDonald PN
J Invest Dermatol; 2008 Oct; 128(10):2508-17. PubMed ID: 18509362
[TBL] [Abstract][Full Text] [Related]
7. The vitamin D receptor is a Wnt effector that controls hair follicle differentiation and specifies tumor type in adult epidermis.
Pálmer HG; Anjos-Afonso F; Carmeliet G; Takeda H; Watt FM
PLoS One; 2008 Jan; 3(1):e1483. PubMed ID: 18213391
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk of Aryl Hydrocarbon Receptor (AHR)- and Vitamin D Receptor (VDR)-signaling in Human Keratinocytes.
Christofi C; Lamnis L; Stark A; Palm H; Römer K; Vogt T; Reichrath J
Anticancer Res; 2022 Oct; 42(10):5049-5067. PubMed ID: 36191995
[TBL] [Abstract][Full Text] [Related]
9. UVB-induced production of 1,25-dihydroxyvitamin D3 and vitamin D activity in human keratinocytes pretreated with a sterol delta7-reductase inhibitor.
Vantieghem K; Kissmeyer AM; De Haes P; Bouillon R; Segaert S
J Cell Biochem; 2006 May; 98(1):81-92. PubMed ID: 16365879
[TBL] [Abstract][Full Text] [Related]
10. Novel mechanisms for the vitamin D receptor (VDR) in the skin and in skin cancer.
Bikle DD; Oda Y; Tu CL; Jiang Y
J Steroid Biochem Mol Biol; 2015 Apr; 148():47-51. PubMed ID: 25445917
[TBL] [Abstract][Full Text] [Related]
11. A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.
Bong YS; Assefnia S; Tuohy T; Neklason DW; Burt RW; Ahn J; Bueno De Mesquita PJ; Byers SW
Oncotarget; 2016 Dec; 7(49):80508-80520. PubMed ID: 27768599
[TBL] [Abstract][Full Text] [Related]
12. UVB radiation-induced β-catenin signaling is enhanced by COX-2 expression in keratinocytes.
Smith KA; Tong X; Abu-Yousif AO; Mikulec CC; Gottardi CJ; Fischer SM; Pelling JC
Mol Carcinog; 2012 Sep; 51(9):734-45. PubMed ID: 21853475
[TBL] [Abstract][Full Text] [Related]
13. The 1,25-dihydroxyvitamin D3-independent actions of the vitamin D receptor in skin.
Dowd DR; MacDonald PN
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):317-21. PubMed ID: 20362670
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells.
Larriba MJ; Valle N; Pálmer HG; Ordóñez-Morán P; Alvarez-Díaz S; Becker KF; Gamallo C; de Herreros AG; González-Sancho JM; Muñoz A
Endocr Relat Cancer; 2007 Mar; 14(1):141-51. PubMed ID: 17395983
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.
Larriba MJ; Ordóñez-Morán P; Chicote I; Martín-Fernández G; Puig I; Muñoz A; Pálmer HG
PLoS One; 2011; 6(8):e23524. PubMed ID: 21858154
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin facilitates ultraviolet B-induced squamous cell carcinoma development.
Chang PL; Hsieh YH; Wang CC; Juliana MM; Tsuruta Y; Timares L; Elmets C; Ho KJ
J Dermatol Sci; 2014 Aug; 75(2):121-32. PubMed ID: 24888687
[TBL] [Abstract][Full Text] [Related]
17. The effect of 1,25 dihydroxyvitamin D3 treatment on the mRNA levels of β catenin target genes in mice with colonic inactivation of both APC alleles.
DeWitt M; Johnson RL; Snyder P; Fleet JC
J Steroid Biochem Mol Biol; 2015 Apr; 148():103-10. PubMed ID: 25597951
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract][Full Text] [Related]
19. The Vitamin D Receptor as Tumor Suppressor in Skin.
Bikle DD
Adv Exp Med Biol; 2020; 1268():285-306. PubMed ID: 32918224
[TBL] [Abstract][Full Text] [Related]
20. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
